Welcome to the new morningstar.co.uk! Learn more about the changes and how our new features help your investing success.

Sensyne Health In New Artificial Intelligence Partnership

(Alliance News) - Sensyne Health PLC on Monday said it has entered a strategic partnership with ...

Alliance News 24 June, 2019 | 2:05PM
Email Form

(Alliance News) - Sensyne Health PLC on Monday said it has entered a strategic partnership with the goal of accelerating drug discovery using artificial intelligence.

The partnership, known as LAB10x, is between clinical AI tech firm Sensyne, drug discovery company Evotec SE, and the University of Oxford - with Oxford University Innovation Ltd and Oxford Sciences Innovation.

The partnership aims toward "accelerating the translation of research in the fields of clinical artificial intelligence and digital health at Oxford into breakthrough digital therapeutics, clinical AI algorithms and to accelerate data-driven drug discovery and development".

Projects will be exclusively sources from University of Oxford researchers, with the technologies developed by LAB10x used to create and analyse patient data and improve outcomes. Initially, the project is supported by a GBP5 million fund for three years.

Sensyne is entitled to equity in LAB10x spin-out companies, as is Evotec and Oxford University.

Paul Drayson, chief executive at Sensyne, said: "LAB10x will leverage Sensyne's expertise in digital health and clinical AI, our regulated development environment and our unique partnership model with the University of Oxford and NHS Trusts to ensure the science is brought through to application as quickly and efficiently as possible - delivering benefits for patients and creating significant value."

Shares in Sensyne were up 2.0% at 124.90 pence on Monday afternoon.

By Anna Farley; annafarley@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Sensyne Health PLC 73.98 GBX -2.66 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation

By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites